Skip to main content
Log in

Epitheliale kindliche Lebertumoren

Eine Übersicht der neuen WHO-Klassifikation für pädiatrische Tumoren

Epithelial childhood liver tumors

An overview of the new WHO classification for pediatric tumors

  • Schwerpunkt: Connective (tissue) pathology: Was uns verbindet!
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Kindliche Lebertumoren sind sehr seltene Tumoren, welche unter 1 % aller kindlichen Malignome ausmachen. Die häufigsten Tumoren im Bereich der Leber stellen Hepatoblastome dar. Im Rahmen dieser Übersicht sollen die epithelialen malignen kindlichen Lebertumoren besprochen werden, wobei insbesondere auf die Morphologie der verschiedenen Hepatoblastomsubtypen eingegangen wird. Zudem werden die anderen malignen Lebertumoren wie der sog. hepatozelluläre Tumor, NOS, sowie der zweithäufigste kindliche Lebertumor, das hepatozelluläre Karzinom, besprochen. Neben den typischen morphologischen Charakteristika werden auch die immunhistochemischen und molekularen Aspekte behandelt, welche helfen können, diese sich teils deutlich ähnelnden Entitäten zu unterscheiden.

Abstract

Pediatric liver tumors are very rare tumors and account for less than 1% of all childhood malignancies. By far the most common tumors are hepatoblastomas. This review discusses epithelial malignant childhood liver tumors, with particular attention to the morphology of the different hepatoblastoma subtypes. In addition, other malignant liver tumors such as the so-called hepatocellular tumor NOS and the second-most common childhood liver tumor, the hepatocellular carcinoma, are discussed. In addition to the typical morphological characteristics, the immunohistochemical and molecular aspects are also be presented, which can help to distinguish these entities with often overlapping morphology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Erdmann F, Grabow D, Kaatsch P, Spix C, Wellbrock M (2020) Jahresbericht 2019 des Deutschen Kinderkrebsregisters

  2. Weinberg AG, Finegold MJ (1983) Primary hepatic tumors of childhood. Hum Pathol 14:512–537

    Article  CAS  Google Scholar 

  3. DeBaun MR, Tucker MA (1998) Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. J Pediatr 132:398–400

    Article  CAS  Google Scholar 

  4. Giardiello FM, Offerhaus JA, Krush AJ (1991) Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 3:766–768

    Article  Google Scholar 

  5. Kato M et al (2009) Hepatoblastoma in a patient with sotos syndrome. J Pediatr 155:937–939

    Article  Google Scholar 

  6. Ikeda H, Matsuyama S, Tanimura M (1997) Association between hepatoblastoma and very low birth weight: A trend or a chance? J Pediatr 130:557–560

    Article  CAS  Google Scholar 

  7. López-Terrada D et al (2014) Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 27:472–491

    Article  Google Scholar 

  8. Haas JE et al (1989) Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64:1082–1095

    Article  CAS  Google Scholar 

  9. Malogolowkin MH et al (2011) Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the children’s oncology group. JCO 29:3301–3306

    Article  Google Scholar 

  10. Ranganathan S, Lopez-Terrada D, Alaggio R (2020) Hepatoblastoma and pediatric hepatocellular carcinoma: an update. Pediatr Dev Pathol 23:79–95

    Article  Google Scholar 

  11. Trobaugh-Lotrario A et al (2021) Small cell undifferentiated histology does not adversely affect outcome in hepatoblastoma: a report from the children’s oncology group (COG) AHEP0731 study committee. JCO 21:803. https://doi.org/10.1200/JCO.21.00803

    Article  CAS  Google Scholar 

  12. Vokuhl C et al (2016) Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?: SCUD Hepatoblastomas. Genes Chromosomes Cancer 55:925–931

    Article  CAS  Google Scholar 

  13. Rutledge J, Beckwith JB, Benjamin D, Haas JE (1983) Absence of immunoperoxidase staining for myoglobin in the malignant rhabdoid tumor of the kidney. Pediatr Pathol 1:93–98

    Article  CAS  Google Scholar 

  14. Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650

    Article  Google Scholar 

  15. Versteege I et al (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206

    Article  CAS  Google Scholar 

  16. Bookhout C, Bouldin TW, Ellison DW (2018) Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4): AT/RT with retained INI1 and BRG1 loss. Neuropathology 38:305–308

    Article  Google Scholar 

  17. Eichenmüller M et al (2014) The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61:1312–1320

    Article  Google Scholar 

  18. Taniguchi K et al (2002) Mutational spectrum of β‑catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21:4863–4871

    Article  CAS  Google Scholar 

  19. Cairo S et al (2020) A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients. Eur J Cancer 141:30–39

    Article  CAS  Google Scholar 

  20. Prokurat A et al (2002) Transitional liver cell tumors (TLCT) in older children and adolescents: A novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 39:510–518

    Article  Google Scholar 

  21. Nagae G et al (2021) Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun 12:5423

    Article  CAS  Google Scholar 

  22. Guichard C et al (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44:694–698

    Article  CAS  Google Scholar 

  23. Cleary SP et al (2013) Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology 58(X):1693–1702

    Article  CAS  Google Scholar 

  24. Katzenstein HM et al (2003) Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97:2006–2012

    Article  Google Scholar 

  25. Rao CV, Asch AS, Yamada HY (2017) Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. CARCIN 38:2–11

    Article  CAS  Google Scholar 

  26. Nault J‑C, Zucman-Rossi J (2016) TERT promoter mutations in primary liver tumors. Clin Res Hepatol Gastroenterol 40:9–14

    Article  CAS  Google Scholar 

  27. Cornella H et al (2015) Unique genomic profile of Fibrolamellar hepatocellular carcinoma. Gastroenterology 148:806–818.e10

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Vokuhl.

Ethics declarations

Interessenkonflikt

J.F. Lau und C. Vokuhl geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Schwerpunktherausgeber

E. Wardelmann, Münster

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lau, J.F., Vokuhl, C. Epitheliale kindliche Lebertumoren. Pathologe 43, 202–209 (2022). https://doi.org/10.1007/s00292-022-01067-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-022-01067-3

Schlüsselwörter

Keywords

Navigation